Under Oregon’s Death with Dignity Act terminally ill patients can use barbiturates, prescribed by a physician, to end their own lives.
Brittany Maynard took her life Saturday at her home in Portland, Oregon, after sharing the very personal decision to do so last month with the world.
Maynard was diagnosed with stage 4 glioblastoma and given six months to live. She sparked a public debate when she spoke out about her controversial decision through photos and a video interview that went viral.
Maynard posted one final message on her Facebook:
Goodbye to all my dear friends and family that I love. Today is the day I have chosen to pass away with dignity in the face of my terminal illness, this terrible brain cancer that has taken so much from me … but would have taken so much more. The world is a beautiful place, travel has been my greatest teacher, my close friends and folks are the greatest givers. I even have a ring of support around my bed as I type … Goodbye world. Spread good energy. Pay it forward!
DONATE TO BIZPAC REVIEW
Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!
- Kamala Harris: ‘Listen, women are getting pregnant every day in America, and this is a real issue’ - July 25, 2022
- How a small border town is dealing with huge consequences of Biden’s border policies - June 25, 2022
- Biden admin expands ‘critical habitats’ for endangered species to include lands they no longer live in - June 25, 2022
Comment
We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.
BPR INSIDER COMMENTS
Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!
Comments are closed.